Literature DB >> 29465664

Knowledge, Practices, and Barriers to HIV Preexposure Prophylaxis Prescribing Among Washington State Medical Providers.

Brian R Wood, Vanessa M McMahan, Kelly Naismith1, Jonathan B Stockton1, Lori A Delaney1, Joanne D Stekler.   

Abstract

BACKGROUND: We aimed to assess HIV preexposure prophylaxis (PrEP) awareness and prescribing practices among Washington State medical providers from diverse professional disciplines and practice types.
METHODS: In May 2016, we administered an anonymous online survey to licensed medical practitioners who provide primary, longitudinal, walk-in, emergency, obstetric, gynecologic, sexually transmitted infection, or family planning care.
RESULTS: Of 735 eligible providers, 64.8% had heard of PrEP. Younger providers and providers with a doctor of medicine degree were more likely to be aware of PrEP compared with older providers (P = 0.0001) and providers of other training backgrounds (advanced registered nurse practitioner, doctor of osteopathic medicine, or physician assistant; P = 0.04). Among providers aware of PrEP, most frequent reported concerns about prescribing were adherence (46.0%) and costs (42.9%). Providers felt very (20.1%) or somewhat (33.8%) comfortable discussing PrEP overall, but very (26.8%) or somewhat (44.7%) uncomfortable discussing cost and insurance issues. The 124 PrEP prescribers reported a median of 2 (range, 1-175; total, 1142) patients prescribed PrEP. Prior authorizations and insurance denials had prevented prescriptions for 28.7% and 12.1% of prescribers, respectively.
CONCLUSIONS: Interventions to improve PrEP access should include education to inform medical providers about PrEP, with particular attention to provider types less likely to be aware. Continued efforts to eliminate cost and insurance barriers and educate providers regarding financial resources would help improve PrEP access.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29465664     DOI: 10.1097/OLQ.0000000000000781

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  26 in total

Review 1.  Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation.

Authors:  Victoria E Powell; Kevin M Gibas; Joshua DuBow; Douglas S Krakower
Journal:  Curr Infect Dis Rep       Date:  2019-06-21       Impact factor: 3.725

2.  PrEParing Providers: The Next Challenge in Implementing Human Immunodeficiency Virus Preexposure Prophylaxis.

Authors:  Christopher B Hurt
Journal:  Sex Transm Dis       Date:  2018-07       Impact factor: 2.830

Review 3.  A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP).

Authors:  Rebecca Touger; Brian R Wood
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

4.  HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.

Authors:  Steven A John; Katherine G Quinn; Benedikt Pleuhs; Jennifer L Walsh; Andrew E Petroll
Journal:  AIDS Behav       Date:  2020-11

5.  Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.

Authors:  Benedikt Pleuhs; Katherine G Quinn; Jennifer L Walsh; Andrew E Petroll; Steven A John
Journal:  AIDS Patient Care STDS       Date:  2020-02-28       Impact factor: 5.078

6.  Predictors of vaccination rates in people living with HIV followed at a specialty care clinic.

Authors:  Tanner M Johnson; Donald G Klepser; Sara H Bares; Kimberly K Scarsi
Journal:  Hum Vaccin Immunother       Date:  2020-09-03       Impact factor: 3.452

7.  Comfort Discussing HIV Pre-exposure Prophylaxis With Patients Among Physicians in an Urban Emergency Department.

Authors:  Brett A Tortelli; Douglas M Char; John S Crane; William G Powderly; Amber Salter; Philip A Chan; Rupa R Patel
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

8.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

9.  Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students.

Authors:  Sarahmona M Przybyla; Kathleen Parks; Jacob Bleasdale; Joshua Sawyer; Diane Morse
Journal:  Curr Pharm Teach Learn       Date:  2019-02-23

10.  Student Education About Pre-exposure Prophylaxis (PrEP) Varies Between Regions of the United States.

Authors:  Samuel R Bunting; Sarah S Garber; Robert H Goldstein; Timothy D Ritchie; Tamzin J Batteson; Timothy J Keyes
Journal:  J Gen Intern Med       Date:  2020-02-20       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.